STOCK TITAN

Mentari Therapeutics (MTRI) Debt by Year

MTRI NASDAQ

Mentari Therapeutics, Inc. held $2.2M in cash and equivalents at the end of fiscal year 2026, and no long-term debt figure is on record for that period. The table below carries 7 fiscal years, from 2020 to 2026, and the quarters Mentari Therapeutics, Inc. has filed alongside them.

FY2026 annual
Long-Term Debt N/A
Cash & Equivalents $2.2M

Ticker history: INM became MTRI (Mentari Therapeutics, Inc.) on . Earlier news and filings retain their original names and dates. View INM history.

Source SEC Filings Latest period Q1 FY2027, ended Sep 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MTRI Debt & Cash by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY26FilingFY25FilingFY24FilingFY23FilingFY22FilingFY21FilingFY20Filing
Long-Term DebtN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$2.2M-79.6%$10.7M+63.5%$6.6M-26.3%$8.9M+44.3%$6.2M-16.1%$7.4M+26.8%$5.8M

MTRI Debt & Cash by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'27FilingQ4'26FilingQ3'26FilingQ2'26FilingQ1'26FilingQ4'25FilingQ3'25FilingQ2'25FilingQ1'25FilingQ4'24FilingQ3'24FilingQ2'24Filing
Long-Term DebtN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cash & Equivalents$1.1M-88.3%$2.2M-79.6%$5.2M+10.2%$7.0M+103.4%$9.3M+67.1%$10.7M+63.5%$4.7M-38.4%$3.4M-64.1%$5.6M-17.1%$6.6M-26.3%$7.6M-20.9%$9.5M-16.7%

What long-term debt means

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.

More Mentari Therapeutics, Inc. financials

Frequently Asked Questions

Mentari Therapeutics, Inc. held $2.2M in cash and equivalents at the end of fiscal year 2026, and no long-term debt figure is on record for that period.

Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what Mentari Therapeutics, Inc. (MTRI) reported on that line in every period on record.